Related references
Note: Only part of the references are listed.Allosteric regulation of epidermal growth factor (EGF) receptor ligand binding by tyrosine kinase inhibitors
Jennifer L. Macdonald-Obermann et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2018)
Alternative packing of EGFR transmembrane domain suggests that protein-lipid interactions underlie signal conduction across membrane
Eduard V. Bocharov et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES (2016)
Trastuzumab, but Not Pertuzumab, Dysregulates HER2 Signaling to Mediate Inhibition of Autophagy and Increase in Reactive Oxygen Species Production in Human Cardiomyocytes
Nishant Mohan et al.
MOLECULAR CANCER THERAPEUTICS (2016)
A Structural Perspective on the Regulation of the Epidermal Growth Factor Receptor
Erika Kovacs et al.
ANNUAL REVIEW OF BIOCHEMISTRY, VOL 84 (2015)
Trastuzumab-induced recruitment of Csk-homologous kinase (CHK) to ErbB2 receptor is associated with ErbB2-Y1248 phosphorylation and ErbB2 degradation to mediate cell growth inhibition
Milos Dokmanovic et al.
CANCER BIOLOGY & THERAPY (2014)
Structural analysis of the EGFR/HER3 heterodimer reveals the molecular basis for activating HER3 mutations
Peter Littlefield et al.
SCIENCE SIGNALING (2014)
The EGFR Family: Not So Prototypical Receptor Tyrosine Kinases
Mark A. Lemmon et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2014)
Coarse-Grained Molecular Simulation of Epidermal Growth Factor Receptor Protein Tyrosine Kinase Multi-Site Self-Phosphorylation
John G. Koland
PLOS COMPUTATIONAL BIOLOGY (2014)
Architecture and Membrane Interactions of the EGF Receptor
Anton Arkhipov et al.
CELL (2013)
Conformational Coupling across the Plasma Membrane in Activation of the EGF Receptor
Nicholas F. Endres et al.
CELL (2013)
Her2 activation mechanism reflects evolutionary preservation of asymmetric ectodomain dimers in the human EGFR family
Anton Arkhipov et al.
ELIFE (2013)
NetworkView: 3D display and analysis of protein•RNA interaction networks
John Eargle et al.
BIOINFORMATICS (2012)
EGFR ligands exhibit functional differences in models of paracrine and autocrine signaling
Kristy J. Wilson et al.
GROWTH FACTORS (2012)
Inhibition of protein-protein interaction of HER2-EGFR and HER2-HER3 by a rationally designed peptidomimetic
Sashikanth Banappagari et al.
JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2012)
Reorienting the Fab Domains of Trastuzumab Results in Potent HER2 Activators
Justin M. Scheer et al.
PLOS ONE (2012)
Fast Photochemical Oxidation of Proteins for Epitope Mapping
Lisa M. Jones et al.
ANALYTICAL CHEMISTRY (2011)
Structural Analysis of the Mechanism of Inhibition and Allosteric Activation of the Kinase Domain of HER2 Protein
Kathleen Aertgeerts et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Mechanism for Activation of the EGF Receptor Catalytic Domain by the Juxtamembrane Segment
Natalia Jura et al.
CELL (2009)
Membrane-anchored growth factors, the epidermal growth factor family: Beyond receptor ligands
Shigeki Higashiyama et al.
CANCER SCIENCE (2008)
Automated Builder and Database of Protein/Membrane Complexes for Molecular Dynamics Simulations
Sunhwan Jo et al.
PLOS ONE (2007)
Activation of a nuclear factor κB/interieukin-1 positive feedback loop by amphiregulin in human breast cancer cells
Katie L. Streicher et al.
MOLECULAR CANCER RESEARCH (2007)
Drug therapy: Trastuzumab - Mechanism of action and use in clinical practice
Clifford A. Hudis
NEW ENGLAND JOURNAL OF MEDICINE (2007)
System for quantifying dynamic protein interactions defines a role for Herceptin in modulating ErbB2 interactions
T. S. Wehrman et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Software news and updates - Carma: A molecular dynamics analysis program
Nicholas M. Glykos
JOURNAL OF COMPUTATIONAL CHEMISTRY (2006)
An allosteric mechanism for activation of the kinase domain of epidermal growth factor receptor
Xuewu Zhang et al.
CELL (2006)
Autocrine, paracrine and juxtacrine signaling by EGFR ligands.
AB Singh et al.
CELLULAR SIGNALLING (2005)
Insights into ErbB signaling from the structure of the ErbB2-pertuzumab complex
MC Franklin et al.
CANCER CELL (2004)
Differential activation of epidermal growth factor (EGF) receptor downstream signaling pathways by betacellulin and EGF
T Saito et al.
ENDOCRINOLOGY (2004)
Monoclonal antibodies inducing conformational changes on the antigen molecule
LP Roguin et al.
SCANDINAVIAN JOURNAL OF IMMUNOLOGY (2003)
Betacellulin and amphiregulin induce upregulation of cyclin D1 and DNA synthesis activity through differential signaling pathways in vascular smooth muscle cells
HS Shin et al.
CIRCULATION RESEARCH (2003)
New analytic approximation to the standard molecular volume definition and its application to generalized born calculations
MS Lee et al.
JOURNAL OF COMPUTATIONAL CHEMISTRY (2003)
The deaf and the dumb: the biology of ErbB-2 and ErbB-3
A Citri et al.
EXPERIMENTAL CELL RESEARCH (2003)
Structure of the extracellular region of HER2 alone and in complex with the Herceptin Fab
HS Cho et al.
NATURE (2003)
The crystal structure of a truncated ErbB2 ectodomain reveals an active conformation, poised to interact with other ErbB receptors
TPJ Garrett et al.
MOLECULAR CELL (2003)
EGF activates its receptor by removing interactions that autoinhibit ectodomain dimerization
KM Ferguson et al.
MOLECULAR CELL (2003)
Crystal structure of a truncated epidermal growth factor receptor extracellular domain bound to transforming growth factor α
TPJ Garrett et al.
CELL (2002)
Crystal structure of the complex of human epidermal growth factor and receptor extracellular domains
H Ogiso et al.
CELL (2002)
Ligand-induced, receptor-mediated dimerization and activation of EGF receptor
J Schlessinger
CELL (2002)
Structure of the extracellular region of HER3 reveals an interdomain tether
HS Cho et al.
SCIENCE (2002)
Analysis of a 10-ns molecular dynamics simulation of mouse acetylcholinesterase
K Tai et al.
BIOPHYSICAL JOURNAL (2001)
Share Paper
